CONGRESS COVERAGE: EHA 2020 – FOCUS ON NHL/CLL
Explore the latest therapeutic developments and translational research in NHL and CLL treatment, advances in dynamic and oftentimes individualized clinical decision-making, and how emerging data will affect ongoing research, development of new compounds, and future treatment paradigms
FACULTY CO-CHAIR
Franck Morschhauser, MD, PhD
Centre Hospitalier Universitaire de Lille Lille, France
FACULTY CO-CHAIR
Thomas Witzig, MD
Mayo Clinic Rochester, MN, USA
Faculty Members
Stephen M. Ansell, MD, PhD
Mayo Clinic, Rochester, MN
Barbara Eichhorst, MD
University of Munich, Munich, Germany
Raul Cordoba, MD, PhD
Fundacion Jimenez Diaz University Hospital, Madrid, Spain
Mathias Rummel, MD, PhD
Justus-Liebig University-Hospital,
Giessen, Germany
Pier Luigi Zinzani, MD, PhD
University of Bologna, Bologna, Italy
REPORT TOPICS INCLUDE
- Updates on DLBCL
- Updates on FL and MCL
- Updates on T-Cell Lymphoma
- Updates on CLL
- Strategic Insights and Key Takeaways
